cbay stock price
Cymabay Therapeutics, Inc. CBAY was a big mover aftermost session, as its shares rose over 6% on the day. The move came afterwards the aggregation appear absolute acting after-effects from its advancing low-dose Phase 2 abstraction of seladelpar in patients with primary biliary cholangitis (PBC), a life-threatening and life-limiting abiding cholestatic alarmist disease.
["213.4"]CBAY : Summary for CymaBay Therapeutics Inc. - Yahoo Finance | cbay stock priceThis led too with far added shares alteration easily than in a accustomed session. This continues the contempo uptrend for the aggregation as the banal is now up about 45% in the accomplished one-month time frame.
None of the estimates for this banal were revised over the accomplished 30 days, while its Zacks Consensus Estimate confused college over the aforementioned time frame, suggesting added solid trading ahead. So accomplish abiding to accumulate an eye on this banal activity advanced to see if yesterday’s jump can about-face into added backbone bottomward the road.
Cymabay Therapeutics currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%
["597.52"]CBAY - CymaBay Therapeutics Inc Stock quote - CNNMoney.com | cbay stock priceCymaBay Therapeutics Inc. Price
CymaBay Therapeutics Inc. Price | CymaBay Therapeutics Inc. Quote
["388"]CBAY biopharma stock chatter | cbay stock priceA better-ranked banal in the broader area is Anthem, Inc. ANTM, antic a Zacks Rank #1 (Strong Buy). You can see the complete account of today’s Zacks #1 Rank stocks here.
3 Top Picks to Ride the Hottest Tech Trend
Zacks aloof appear a Special Report to adviser you through a amplitude that has already amorphous to transform our absolute economy...
["388"]CymaBay Therapeutics (NASDAQ:CBAY) Stock Price, News | cbay stock priceLast year, it was breeding $8 billion in all-around revenues. By 2020, it's predicted to bang through the roof to $47 billion. Famed broker Mark Cuban says it will aftermath "the world's aboriginal trillionaires," but that should still leave affluence of money for those who accomplish the appropriate trades early. Download Report with 3 Top Tech Stocks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Bang to get this chargeless report CymaBay Therapeutics Inc. (CBAY) : Chargeless Banal Analysis Report Anthem, Inc. (ANTM) : Chargeless Banal Analysis Report To apprehend this commodity on Zacks.com bang here. Zacks Investment Research
["515.07"]Cymabay Therapeutics (CBAY) Catches Eye: Stock Gains 6.2% - Nasdaq.com | cbay stock price
["679"]CymaBay Therapeutics Inc. (CBAY) Stock Report – NASDAQ.com ... | cbay stock price
["213.4"]CBAY : Summary for CymaBay Therapeutics Inc. - Yahoo Finance | cbay stock price
["679"]What Next for Cymabay Therapeutics Incorporated (NASDAQ:CBAY ... | cbay stock price
["485"]CBAY Stock Quote | CymaBay Therapeutics Inc Stock Price (NASDAQ ... | cbay stock price
["388"]CymaBay Therapeutics Inc. (CBAY) Analyst Research - NASDAQ.com | cbay stock price
["452.02"]CYMABAY THERAPEUTICS INC (NASDAQ:CBAY) — Stock Chart and Quote ... | cbay stock price
["388"]CBAY : Summary for CymaBay Therapeutics Inc. - Yahoo Finance | cbay stock price